Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Lee and K
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
They are based on the latest medical knowledge and advice from experts around the world
GHK-Cu provides essential support through optimization of collagen quality via TGF- pathway activation and copper delivery for lysyl oxidase-mediated cross-linking that determines tissue mechanical properties
TESTED FOR: QA Verified Purity Weight Endotoxins (LPS) Product Details Bulk discounts Ships same day for orders placed before 3 PM PT Free shipping for orders over $100 Backed by our Return Policy Additional Information 5-AMINO-1MQ PeakForm 5-AMINO-1MQ is available in 5 mg and 50 mg vial options
US$ 24.78
US$ 25.36
US$ 26.20
US$ 20.46